Trump says Pfizer will sell some drugs at 'most‑favored nation' prices, claiming 50–100% cuts
President Trump announced a deal with Pfizer saying some drugs would be sold on a White House portal at "most‑favored nation" prices and claimed cuts of 50–100%; Pfizer said its direct‑to‑consumer prices on the portal will be "50% lower on average," but specific terms are confidential. The administration said TrumpRx.gov will launch in 2026 to route primarily uninsured patients to companies' direct‑to‑consumer fulfillment sites, and experts warned the plan may have limited benefit for insured consumers while Medicaid already secures low prices.
Health
Corporate News
Politics
Economy
🔍 Key Facts
- President Trump announced a deal with Pfizer saying some medications will be sold at a "most‑favored nation" cost and claimed some drug prices could fall by 50–100%.
- Pfizer told reporters its direct‑to‑consumer prices on the announced portal will be "50% lower on average," while specific terms of the agreement remain confidential.
- The White House unveiled a federal website, TrumpRx.gov, to route consumers to discounted direct‑to‑consumer drug purchases; the site is slated to launch in 2026.
- Administration officials said the discounts would be available to patients not using insurance and that the website will direct orders to pharmaceutical companies' own direct‑to‑consumer fulfillment sites.
- Named officials present at the Oval Office briefing included CMS Administrator Mehmet Oz, FDA Commissioner Martin Makary, HHS Secretary Robert F. Kennedy Jr., and Pfizer CEO Albert Bourla.
- Experts (including Ameet Sarpatwari of Harvard) warned the plan may be underwhelming for the average insured consumer and noted that Medicaid already secures low drug prices for many drugs.
- NPR framed the Pfizer pricing announcement as part of broader White House drug‑pricing initiatives and reported the news alongside coverage of the government shutdown.
📍 Contextual Background
- On 2025-09-22, President Donald Trump publicly stated that acetaminophen (Tylenol) "can be associated with a very increased risk of autism" and linked Tylenol with autism.
- An FDA press release stated that some studies have found an association between acetaminophen and autism but those studies have not established causation.
- On 2025-09-22, the U.S. Food and Drug Administration (FDA) said it would begin the process of updating the safety label for Tylenol and acetaminophen.
- At the 2025-09-22 White House press conference where President Trump linked acetaminophen to autism, the individuals reported as flanking him included Jay Bhattacharya, Marty Makary, Robert F. Kennedy Jr., and Mehmet Oz.
📰 Sources (4)
What happens now that the government has shut down. And, a pricing deal with Pfizer
New information:
- NPR references a new pricing deal with Pfizer as part of the broader White House announcements tied to drug‑pricing initiatives (reported alongside the shutdown coverage).
President announces TrumpRx website for drugs, and pricing deal with Pfizer
New information:
- White House announced a federal website, TrumpRx.gov, to route consumers to discounted direct‑to‑consumer drug purchases; site to launch in 2026.
- Pfizer told reporters its direct‑to‑consumer prices on the portal will be '50% lower on average' per a company press release; specific terms of the agreement remain confidential.
- Administration officials said the discounts would be available to patients not using insurance and the website would direct orders to pharmaceutical companies' own direct‑to‑consumer fulfillment sites.
- Named officials present at the Oval Office briefing: CMS Administrator Mehmet Oz, FDA Commissioner Martin Makary, HHS Secretary Robert F. Kennedy Jr., and Pfizer CEO Albert Bourla.
- Reporting includes expert reaction (Ameet Sarpatwari, Harvard) cautioning the plan may be underwhelming for average insured consumers and explaining Medicaid already pays low prices.
Trump says some medications will be sold at reduced "most-favored nation cost" in Pfizer deal
New information:
- President Trump said some medications will be sold at a 'most‑favored nation cost' under a deal with Pfizer.
- The president claimed some drug prices could fall by 50%–100%.